WUXI BIO (02269) Company Profile - Company Info, Industry & Management

返回 Overview News Financials Shareholders Profile IPO ›

Industry

CRO/CDMO 0.65%

14 stocks in this industry

0 >7%

1 5~7%

1 3~5%

5 0~3%

1 0%

6 0~3%

0 3~5%

0 5~7%

0 >7%

Down 7 Up 6

Industry RankingsValue (HKD)Rank

Revenue (Last FY)25.55B3/14

Net Profit (Last FY)5.76B2/14

ROE (Last FY)10.39%5/14

Change is the 2026-10-12 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

药明生物技术有限公司 Executive Director

陈智胜 Executive Director

Sherry Xuejun Gu Executive Director

李革 Non-Executive Director

曹彦凌 Non-Executive Director

缪静雯 Non-Executive Director

William Robert Keller Independent Non-Executive Director

Kenneth Walton Hitchner III Independent Non-Executive Director

戴国良 Independent Non-Executive Director

陈珏 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-06-06.

About this page

This page shows WUXI BIO (02269) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

WUXI BIO 02269

Company Information

Industry

Management

WUXI BIO 02269·

Company Information

Industry

Management

WUXI BIO 02269